Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Goldbarg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Anticancer Research|April 3, 2014
Pertuzumab: development beyond breast cancerPhilippe Barthélémy, Julie Leblanc, Veronica Goldbarg, et al.
Oncology|September 24, 2014
Adherence and patients' attitudes to oral anticancer drugs: a prospective series of 201 patients focusing on targeted therapiesPhilippe Barthélémy, Irène Asmane-De la Porte, Nicolas Meyer, et al.
American Journal of Human Genetics|October 1, 2021
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approachSandrine M Caputo, Lisa Golmard, Mélanie Léone, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Anticancer Research|April 3, 2014
Pertuzumab: development beyond breast cancerPhilippe Barthélémy, Julie Leblanc, Veronica Goldbarg, et al.
Oncology|September 24, 2014
Adherence and patients' attitudes to oral anticancer drugs: a prospective series of 201 patients focusing on targeted therapiesPhilippe Barthélémy, Irène Asmane-De la Porte, Nicolas Meyer, et al.
American Journal of Human Genetics|October 1, 2021
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approachSandrine M Caputo, Lisa Golmard, Mélanie Léone, et al.
Pageof 1